Target of the Week - CD73 Antibodies

Dear Researcher, Abgent offers a portfolio of antibodies for the the detection of CD73 (NT5E). Applications include western blotting, immunohistochemistry, and ELISA for human and mouse models. CD73 (NT5E or Ecto-5-prime-nucleotidase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, with AMP the preferred substrate. CD73 on immune cells is emerging as an important pathway and therapeutic target in cardiovascular and autoimmune disorders. To find the right CD73 antibody for your research, please visit Abgent CD73 Antibodies. |
|
IHC for Cat# AO1908a Polyclonal CD73 Antibody |
WB for Cat# AM2223a Monoclonal CD73 Antibody |
IHC for Cat# AP2014A Polyclonal CD73 Antibody |
Abgent is highlighted in the Antibody Quality Review published by Nature.
|
|
|






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.